China Universal Asset Management Co., Ltd.

Position in ABSI — Absci Corp

CIK 1906594 SHANGHAI, F4

Position in ABSI

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$128,055

+$7,640 QoQ

Shares Held

42,685

+23.7% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

China Universal Asset Management Co., Ltd. holds $172,354,976 across 224 Biotechnology names. ABSI ranks #147 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,902	$19,603,999
2	REGN	Regeneron Pharmaceuticals, Inc.	21,361	$16,504,363
3	ALNY	Alnylam Pharmaceuticals, Inc.	27,266	$9,021,501
4	INSM	INSMED Inc	47,015	$7,687,892
5	RPRX	Royalty Pharma plc	130,447	$6,257,542
6	IONS	Ionis Pharmaceuticals Inc	77,315	$5,805,583
7	ARGX	Argenx SE	5,035	$3,676,808
8	MRNA	Moderna, Inc.	70,085	$3,560,318

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$128,055	42,685	+23.7%	Shares	Sole	2026-04-28
2025-12-31	$120,415	34,503	+31.6%	Shares	Sole	2026-01-29
2025-09-30	$79,675	26,209	+2.3%	Shares	Sole	2025-11-10
2025-06-30	$65,843	25,620	+11.2%	Shares	Sole	2025-08-28
2025-03-31	$57,825	23,038	-5.4%	Shares	Sole	2025-04-30
2024-12-31	$63,807	24,354	+922.0%	Shares	Sole	2025-01-24
2023-09-30	$3,145	2,383	+96.6%	Shares	Sole	2024-05-22
2023-06-30	$1,842	1,212	-3.2%	Shares	Sole	2024-05-22
2023-03-31	$2,191	1,252	+33.3%	Shares	Sole	2024-05-22
2022-12-31	$1,971	939	+8.1%	Shares	Sole	2024-05-22
2022-09-30	$2,719	869	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.